Biological Warfare
IGEN s Collaboration With U.S. Army On Toxins Gets New Emphasis
Published in Medical Letter on the CDC and FDA, November 25th, 2001
IGEN International, Inc.'s, Cooperative Research and Development Agreement (CRADA) with the U.S. Army Medical Research Institute of Infectious Diseases (USAMRIID) is receiving additional emphasis in an effort to develop tests, based on IGEN's proprietary ORIGEN technology, that can rapidly detect food-, water-, and environmentally borne toxins. The company anticipates that successful completion of this CRADA would lead to expanded sales of instrumentation and reagents.
Use of the IGEN M-SERIES M8 analyzer allows for more samples to be processed and analyzed at one time, according to IGEN, and ultimately for rapid assay design and optimization, decreasing the time...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Letter on the CDC and FDA
More Articles from Medical Letter on the CDC and FDA
- Anthrax
Bayer, HHS Complete Cipro Agreement - Blood Safety
Duke Surgeon: Use of Common Clotting Agent Should Be Restricted - Bioterrorism
Drug Companies Offer Skills To Combat Chemical, Germ Warfare - Diet and Nutrition
Study Finds Women In Ivory Coast Need Greater Energy Than Men - Insulin Resistance
SpectRx Gets Third Grant From CDC For Continuous Glucose Monitoring - Anthrax
BioPort May Resume Vaccine Production By End Of November - More from this issue of Medical Letter on the CDC and FDA
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
